Pay in 4 interest-free payments of $6.17 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Designation: FOR RESEARCH USE ONLY
At 5mg/mL concentration, each 0.01mL increment represents 50mcg peptideacceptable precision for protocols dosing 250500mcg per injection
Options for prandial glucose management in type 2 diabetes patients using basal insulin: addition of a short-acting GLP-1 analogue versus progression to basal-bolus therapy
Quality control risk Most BPC-157 sold in the U.S
The largest private insurers and their Wegovy coverage policies as of April 2026: Manulife: Covers with prior authorization, BMI 30 or 27 with comorbidity, 20% copay Sun Life: Covers with prior authorization, requires 6-month lifestyle modification documentation, 25% copay Great-West Life (Canada Life): Covers on select plans only, 30% copay, annual spending cap of CAD $3,000 Green Shield Canada: Covers with prior authorization, no annual cap, 20% copay Blue Cross (varies by province): Coverage varies
